Naturally Inspired Report

As COVID-19 continues to spread around the world and infect many people, medical experts are continually finding ways to treat the virus. A new study suggests that a common HIV medication may also provide protection against a COVID infection (via HealthDay). The researchers discovered that people who were being treated for HIV with antiretroviral treatment (ART) with protease inhibitors had a lower risk of being infected with COVID-19. Protease inhibitors work by blocking an enzyme that viruses need to further infect the body.

“Protease inhibitor drugs have a long history of use, a good safety profile, and are generally well-tolerated. By attacking the virus before it has a chance to multiply, they potentially offer an opportunity to prevent the spread of infections and mutation of future variants,” said study author Dr. Steve Nguala who works at the Intercommunal Hospital Center of Villeneuve-Saint-Georges and the General Hospital of Melun, France. Although this study shows promise for future treatments of COVID-19, more studies are needed on the topic.

READ THE REST OF THE ARTICLE HERE